MRI-Volumetry in the Evaluation of Shunt Treatment for Hydrocephalus
1 other identifier
interventional
36
1 country
1
Brief Summary
This randomized, double-blinded, cross-over study aim to evaluate the effects of shunt treatment in idiopathic normal pressure hydrocephalus (iNPH) by measuring cerebral ventricular volume and clinical symptoms at different shunt opening pressures. Further, proteins in the cerebrospinal fluid (CSF) will be compared before and after shunt surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 10, 2017
CompletedFirst Submitted
Initial submission to the registry
July 19, 2020
CompletedFirst Posted
Study publicly available on registry
October 22, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 28, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 28, 2021
CompletedNovember 8, 2022
November 1, 2022
4.1 years
July 19, 2020
November 2, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Ventricular volume at different shunt settings (mL)
Change in ventricular volume (ml) measured by MRI
Assessed before surgery and at one, two and, three months and three months plus one day post surgery.
Time of "Timed Up and Go" test at different shunt settings
Change in total walking time (sec) on "Timed Up and Go".
Assessed before surgery and at one, two and, three months and three months plus one day post surgery.
Time of 10m walking test at different shunt settings
Change in total walking time (sec) on 10m walking test.
Assessed before surgery and at one, two and, three months and three months plus one day post surgery.
Secondary Outcomes (27)
Ventricular versus lumbar cerebrospinal fluid composition determined by mass spectrometry
Cerebrospinal fluid is collected during diagnostic procedures before surgery, during surgery and three months and one day after surgery.
Change in CSF composition after surgery determined by mass spectrometry
Cerebrospinal fluid is collected during diagnostic procedures before surgery, during surgery and three months and one day after surgery.
Number of steps of "Timed Up and Go" test at different shunt settings
Assessed before surgery and at one, two and, three months and three months plus one day post surgery.
Number of steps of "Timed Up and Go" test at different time points regardless of shunt setting
Assessed before surgery and at one, two and, three months and three months plus one day post surgery.
Number of steps on 10m walking test at different shunt settings
Assessed before surgery and at one, two and, three months and three months plus one day post surgery.
- +22 more secondary outcomes
Study Arms (2)
High initial
EXPERIMENTALAt the one month follow-up, the shunt is adjusted into a high opening pressure (2.5), which is crossed over to 1.0 at the two months follow-up. At the three months follow-up the opening pressure is set at 0.5 until the next day.
Low initial
EXPERIMENTALAt the one month follow-up, the shunt is adjusted into a low opening pressure (1.0), which is crossed over to 2.5 at the two months follow-up. At the three months follow-up the opening pressure is set at 0.5 until the next day.
Interventions
The ventriculoperitoneal shunt (Strata®) opening pressure can be changed using a magnetic tool. The possible settings are 0.5, 1.0, 1.5, 2.0, 2.5 with a higher setting number corresponding to a higher opening pressure and less drainage through the shunt. All settings are used in routine clinical practice.
Eligibility Criteria
You may qualify if:
- Diagnosis of idiopathic normal pressure hydrocephalus and planned treatment with shunt surgery.
You may not qualify if:
- Ongoing anticoagulation treatment
- Ongoing Clopidogrel treatment
- Mini mental state examination results of 15 or lower.
- Contraindications to magnetic resonance imaging.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Neurology Clinic, Östersund Hospital
Östersund, Jämtland County, 83183, Sweden
Related Publications (1)
Liden S, Farahmand D, Laurell K. Volumetric effect of shunt adjustments in normal pressure hydrocephalus: a randomized, double-blind trial. J Neurosurg. 2023 Nov 17;140(5):1493-1500. doi: 10.3171/2023.9.JNS23668. Print 2024 May 1.
PMID: 37976516DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Katarina Laurell, MD, PhD
Uppsala University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Shunt setting at the two months and three months follow up.
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Lecturer/Associate Professor
Study Record Dates
First Submitted
July 19, 2020
First Posted
October 22, 2020
Study Start
October 10, 2017
Primary Completion
October 28, 2021
Study Completion
October 28, 2021
Last Updated
November 8, 2022
Record last verified: 2022-11
Data Sharing
- IPD Sharing
- Will not share